Digestive Diseases and Sciences

, Volume 51, Issue 11, pp 1962–1966 | Cite as

Is Hepatitis C Virus Positivity a Contributing Factor to Occult Hepatitis B Virus Infection in Hemodialysis Patients?

  • Mehmet Kanbay
  • Gurden Gur
  • Ali Akcay
  • Haldun Selcuk
  • Ugur Yilmaz
  • Hande Arslan
  • Sedat Boyacioglu
  • Fatma Nurhan Ozdemir
Original Article

Abstract

Hepatitis B (HBV) infections continue to occur in adult hemodialysis units. Occult HBV infection (serum hepatitis B surface antigen [HBsAg] negative but HBV DNA positive) may be a contributing factor in these patients. This study was designed to (1) investigate the prevalence of occult HBV infection in hemodialysis patients and (2) compare the prevalence of occult HBV infection among hepatitis C (HCV)-positive and HCV-negative hemodialysis patients. The study included 138 patients on chronic hemodialysis. Eighty-four patients were HCV positive and 54 were HCV negative. HBV DNA testing was performed by polymerase chain reaction. We also recorded general characteristics of the patients, duration of hemodialysis, and serum alanine aminotransferase and aspartate aminotransferase levels. Twenty-one (15.2%) of the 138 hemodialysis patients were HBV DNA positive. Nine (16.6%) of the 54 anti-HCV antibody negative hemodialysis patients were HBV DNA positive. Twelve (14.2%) of the 84 anti-HCV antibody positive patients were HBV DNA positive. The prevalence in anti-HCV Ab positive and negative hemodialysis patients were same (P > .05). Hemodialysis duration, demographic features, and biochemical parameters were not significantly different in patients with and without occult HBV infection in both HCV-positive and -negative hemodialysis patients (P > .05). HCV positivity is not a contributing factor to occult HBV infection in hemodialysis patients. None of the parameters tested help to distinguish patients with occult HBV infection from those who are HBV DNA negative.

Keywords

Occult HBV infection Hemodialysis HCV infection 

References

  1. 1.
    Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337:1733–1745PubMedCrossRefGoogle Scholar
  2. 2.
    Alter MJ (2003) Epidemiology and prevention of hepatitis B. Semin Liver Dis 23:39–46PubMedCrossRefGoogle Scholar
  3. 3.
    Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely ‘occult’? Hepatology 34:194–203PubMedCrossRefGoogle Scholar
  4. 4.
    Hu Q (2002) Occult hepatitis B infection and its clinical implications. J Viral Hep 9:243–257CrossRefGoogle Scholar
  5. 5.
    Torbenson M, Thomas DL (2002) Occult hepatitis B infection. Lancet Infect Dis 2: 479–486PubMedCrossRefGoogle Scholar
  6. 6.
    Mistik R, Balik İ (2003) Türkiye’de viral hepatitlerin epidemiyolojik analizi. In: Kilicturgay K, Badur S (eds) Viral hepatit. Viral Hepatitle Savaşım Derneği, Istanbul, p 0–55Google Scholar
  7. 7.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimando G (1999) Occult hepatitis B infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22–26PubMedCrossRefGoogle Scholar
  8. 8.
    Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S (1998) Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol 54:249–255PubMedCrossRefGoogle Scholar
  9. 9.
    Sheu JC, Huang GT, Shih LN, Lee HC, Chou JT, Wang PH, Lee MY, Lai CY, Chen DS (1992) Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 103:1322–1327PubMedGoogle Scholar
  10. 10.
    Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P (1997) Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol 51:313–318PubMedCrossRefGoogle Scholar
  11. 11.
    Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, Kushiyama Y, Uchida Y, Ihihara S, Akagi S, Watanebe M, Kinoshita Y (1999) Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 58:201–207PubMedCrossRefGoogle Scholar
  12. 12.
    Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, Gutkin A, Bernstein K, Giulivi A, Osiowy C (2004) Occult hepatitis B virus infection in a North American adult hemodialysis patient population. 40:1072–1077Google Scholar
  13. 13.
    Besisik F, Karaca C, Akyuz F, Horosanli S, Onel D, Badur S, Sever MS, Danalioglu A, Demir K, Kaymakoglu S, Cakaloglu Y, Okten A (2003) Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 38:506–510PubMedCrossRefGoogle Scholar
  14. 14.
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, et al (1995) The risk of transmission of hepatitis B from HBsAg (-), HBcAb positive, HBIgM (-) organ donors. Transplantation 59:230–234PubMedGoogle Scholar
  15. 15.
    Baginski I, Chemin I, Hantz O, Pichoud C, Jullien AM, Chevre JC, Li JS, Vitvitski L, Sninsky JJ, Trepo C (1992) Transmission of serologically silent hepatitis B virus along with hepatitis C in two cases of posttransfusion hepatitis. Transfusion 32:215–220PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Mehmet Kanbay
    • 1
  • Gurden Gur
    • 1
  • Ali Akcay
    • 1
  • Haldun Selcuk
    • 2
  • Ugur Yilmaz
    • 2
  • Hande Arslan
    • 2
  • Sedat Boyacioglu
    • 2
  • Fatma Nurhan Ozdemir
    • 3
  1. 1.Department of Internal MedicineBaskent University Faculty of MedicineAnkaraTurkey
  2. 2.Department of GastroenterologyBaskent University Faculty of MedicineAnkaraTurkey
  3. 3.Department of NephrologyBaskent University Faculty of MedicineAnkaraTurkey

Personalised recommendations